Logo image of NEPH

NEPHROS INC (NEPH) Stock Fundamental Analysis

NASDAQ:NEPH - Nasdaq - US6406714005 - Common Stock - Currency: USD

4  -0.12 (-2.91%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NEPH. NEPH was compared to 127 industry peers in the Machinery industry. No worries on liquidiy or solvency for NEPH as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, NEPH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NEPH was profitable.
In the past year NEPH had a positive cash flow from operations.
NEPH had negative earnings in 4 of the past 5 years.
In the past 5 years NEPH reported 4 times negative operating cash flow.
NEPH Yearly Net Income VS EBIT VS OCF VS FCFNEPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of NEPH (6.80%) is better than 64.57% of its industry peers.
NEPH has a Return On Equity (8.62%) which is in line with its industry peers.
NEPH's Return On Invested Capital of 6.26% is in line compared to the rest of the industry. NEPH outperforms 46.46% of its industry peers.
Industry RankSector Rank
ROA 6.8%
ROE 8.62%
ROIC 6.26%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
NEPH Yearly ROA, ROE, ROICNEPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

NEPH has a Profit Margin of 5.16%. This is comparable to the rest of the industry: NEPH outperforms 48.82% of its industry peers.
NEPH has a worse Operating Margin (4.98%) than 62.20% of its industry peers.
Looking at the Gross Margin, with a value of 62.45%, NEPH belongs to the top of the industry, outperforming 97.64% of the companies in the same industry.
NEPH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.98%
PM (TTM) 5.16%
GM 62.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
NEPH Yearly Profit, Operating, Gross MarginsNEPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NEPH is destroying value.
The number of shares outstanding for NEPH remains at a similar level compared to 1 year ago.
NEPH has more shares outstanding than it did 5 years ago.
NEPH has a worse debt/assets ratio than last year.
NEPH Yearly Shares OutstandingNEPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NEPH Yearly Total Debt VS Total AssetsNEPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -4.26, we must say that NEPH is in the distress zone and has some risk of bankruptcy.
NEPH has a Altman-Z score of -4.26. This is amonst the worse of the industry: NEPH underperforms 87.40% of its industry peers.
The Debt to FCF ratio of NEPH is 0.05, which is an excellent value as it means it would take NEPH, only 0.05 years of fcf income to pay off all of its debts.
NEPH has a Debt to FCF ratio of 0.05. This is amongst the best in the industry. NEPH outperforms 91.34% of its industry peers.
NEPH has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, NEPH belongs to the best of the industry, outperforming 84.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z -4.26
ROIC/WACC0.63
WACC9.9%
NEPH Yearly LT Debt VS Equity VS FCFNEPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 5.92 indicates that NEPH has no problem at all paying its short term obligations.
NEPH's Current ratio of 5.92 is amongst the best of the industry. NEPH outperforms 94.49% of its industry peers.
A Quick Ratio of 4.64 indicates that NEPH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.64, NEPH belongs to the top of the industry, outperforming 94.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.92
Quick Ratio 4.64
NEPH Yearly Current Assets VS Current LiabilitesNEPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

5

3. Growth

3.1 Past

NEPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 192.31%, which is quite impressive.
NEPH shows a decrease in Revenue. In the last year, the revenue decreased by -0.53%.
The Revenue has been growing slightly by 6.51% on average over the past years.
EPS 1Y (TTM)192.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)-0.53%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.89%

3.2 Future

Based on estimates for the next years, NEPH will show a very strong growth in Earnings Per Share. The EPS will grow by 5422130327.01% on average per year.
The Revenue is expected to grow by 14.70% on average over the next years. This is quite good.
EPS Next Y146997491837372900%
EPS Next 2Y5422130327.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.25%
Revenue Next 2Y14.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NEPH Yearly Revenue VS EstimatesNEPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
NEPH Yearly EPS VS EstimatesNEPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.33, the valuation of NEPH can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of NEPH indicates a slightly more expensive valuation: NEPH is more expensive than 64.57% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.93, NEPH is valued a bit more expensive.
With a Price/Forward Earnings ratio of 392.16, NEPH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NEPH indicates a slightly more expensive valuation: NEPH is more expensive than 70.87% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of NEPH to the average of the S&P500 Index (35.31), we can say NEPH is valued expensively.
Industry RankSector Rank
PE 33.33
Fwd PE 392.16
NEPH Price Earnings VS Forward Price EarningsNEPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NEPH indicates a slightly more expensive valuation: NEPH is more expensive than 75.59% of the companies listed in the same industry.
69.29% of the companies in the same industry are cheaper than NEPH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 94.85
EV/EBITDA 43.29
NEPH Per share dataNEPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NEPH's earnings are expected to grow with 5422130327.01% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y5422130327.01%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NEPH!.
Industry RankSector Rank
Dividend Yield N/A

NEPHROS INC

NASDAQ:NEPH (8/14/2025, 8:00:01 PM)

4

-0.12 (-2.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05
Inst Owners44.01%
Inst Owner Change-0.2%
Ins Owners10.74%
Ins Owner Change0%
Market Cap42.40M
Analysts82.5
Price Target4.85 (21.25%)
Short Float %0.04%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)688.24%
Min EPS beat(2)296.08%
Max EPS beat(2)1080.39%
EPS beat(4)3
Avg EPS beat(4)369.61%
Min EPS beat(4)-96.08%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)186.58%
EPS beat(12)7
Avg EPS beat(12)103.11%
EPS beat(16)8
Avg EPS beat(16)71.4%
Revenue beat(2)2
Avg Revenue beat(2)18.61%
Min Revenue beat(2)6.29%
Max Revenue beat(2)30.93%
Revenue beat(4)2
Avg Revenue beat(4)4.59%
Min Revenue beat(4)-17.42%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)1.96%
Revenue beat(12)5
Avg Revenue beat(12)-0.04%
Revenue beat(16)5
Avg Revenue beat(16)-3.1%
PT rev (1m)0%
PT rev (3m)5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-600%
EPS NY rev (1m)0%
EPS NY rev (3m)-75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.17%
Valuation
Industry RankSector Rank
PE 33.33
Fwd PE 392.16
P/S 2.73
P/FCF 94.85
P/OCF 84.46
P/B 4.56
P/tB 5.31
EV/EBITDA 43.29
EPS(TTM)0.12
EY3%
EPS(NY)0.01
Fwd EY0.26%
FCF(TTM)0.04
FCFY1.05%
OCF(TTM)0.05
OCFY1.18%
SpS1.46
BVpS0.88
TBVpS0.75
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.8%
ROE 8.62%
ROCE 7.52%
ROIC 6.26%
ROICexc 10.39%
ROICexgc 13.16%
OM 4.98%
PM (TTM) 5.16%
GM 62.45%
FCFM 2.88%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score6
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.02
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 772
Cash Conversion 54.86%
Profit Quality 55.81%
Current Ratio 5.92
Quick Ratio 4.64
Altman-Z -4.26
F-Score6
WACC9.9%
ROIC/WACC0.63
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)192.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next Y146997491837372900%
EPS Next 2Y5422130327.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.53%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.89%
Revenue Next Year17.25%
Revenue Next 2Y14.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y151.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y135.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.65%
OCF growth 3YN/A
OCF growth 5YN/A